Clinical trial
Safety Study of Anti-Asthma Agent BMEC-1217B
NCT00425971 · Medigreen Biotechnology Corp., Industry · Unknown status
Key facts
| NCT number | NCT00425971 |
|---|---|
| Title | Safety Study of Anti-Asthma Agent BMEC-1217B |
| Official title | A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating Safety Study of BMEC-1217B, in Healthy Volunteers |
| Lead sponsor | Medigreen Biotechnology Corp., Industry |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | BMEC-1217B |
| Enrollment | 32 |
| Start date | Jul 1, 2008 |
| First posted | Jan 24, 2007 |
| Last update posted | Sep 4, 2008 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: